To assess the associations of semaglutide with incident CUD (first time diagnosis of CUD), the study population included 83,189 patients who had active medical encounters for the diagnosis of obesity in 6/202112/2022, were for the first time (new users design) prescribed semaglutide or non-GLP-1RA anti-obesity medications (bupropion, naltrexone, orlistat, topiramate, phentermine) [39] during 6/2021-12/2022 (time zero or index event), had no diagnosis of CUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities (T2D, hypertension, hypercholesterolemia, hyperlipidemia, heart diseases, stroke) on or before the index event
Beyond hemolysis, recent evidence suggests a role for microvesicle formation and mitochondrial retention in oxidatively-stressed RBCs in potentiating immune activation (75, 76)
Remember, consistency and patience are key, as building and retaining muscle is a long-term pursuit
34 IlicS.BrcicI.MesterM.FilipovicM.SeverM.KlicekR.et al (2009)
